Evidence map›Paper›PMID 33043270›Full record

ArticleNorthern clinics of Istanbul2020

Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia.

Suna Kilinc, Ozlem Bostan, Meltem Erol, Saide Erturk, Damla Dilek, Ozgul Yigit

Abstract readCase Reports
In one paragraph

Article in Northern clinics of Istanbul, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Suna KilincDepartment of Pediatric Endocrinology, Istanbul Bagcilar Training and Research Hospital, Istanbul, Turkey.
Ozlem BostanDepartment of Pediatrics, Istanbul Bagcilar Training and Research Hospital, Istanbul, Turkey.
Meltem ErolDepartment of Pediatrics, Istanbul Bagcilar Training and Research Hospital, Istanbul, Turkey.
Saide ErturkDepartment of Pediatrics, Istanbul Esenler Obstetrics and Pediatrics Hospital, Istanbul, Turkey.
Damla DilekDepartment of Pediatrics, Istanbul Bagcilar Training and Research Hospital, Istanbul, Turkey.
Ozgul YigitDepartment of Pediatrics, Istanbul Bagcilar Training and Research Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypercalcemia is a common metabolic abnormality in children and generally occurs due to hyperparathyroidism, vitamin D toxicity, some genetic disorders and malignant diseases. Granulomatous diseases are a rare cause of hypercalcemia in children, which are usually mild and asymptomatic. Severe hypercalcemia in granulomatous diseases has also been reported in the literature. Here, we report a child presenting with severe hypercalcemia secondary to miliary tuberculosis with successful management with bisphosphonate treatment. Increased 1,25(OH)2D3 synthesis by activated macrophages in the granuloma tissue is the major mechanism of hypercalcemia in tuberculosis.

Indexed as

Bisphosphonateshypercalcemiamiliary tuberculosispamidronate-disodium

Identifiers

PMID33043270
PMCPMC7521098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.